PCN29 COST-EFFECTIVENESS OF MAINTENANCE RITUXIMAB TREATMENT AFTER SECOND LINE THERAPY IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPHOMA IN SWEDEN
Abstract
Authors
F Kasteng M Erlanson H Hagberg E Kimby T Relander J Lundkvist